INO Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.

$1.83  +0.11 (6.11%)
As of 10/04/2022 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/21/2001
Outstanding shares:  249,400,477
Average volume:  5,579,918
Market cap:   $430,215,823
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BN5H5K1
Valuation   (See tab for details)
PE ratio:   -1.31
PB ratio:   1.10
PS ratio:   268.43
Return on equity:   -92.47%
Net income %:   -20,485.93%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy